Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Golar LNG's 1st Quarter 2026 results will be released before the market opens on Wednesday, May 20, 2026. In connection with this a webcast presentation will be held at 08:00am Eastern Time (1:00pm...
-
PRINCETON, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving...
-
Procurement & Supply Chain LIVE: US Summit brings global leaders to Chicago on 21–22 April to share strategies on digital transformation, sustainability an
-
Austin, April 07, 2026 (GLOBE NEWSWIRE) -- The Ambient Intelligence Market size was valued to be valued at 32.60 billion in 2025. It is anticipated to grow to 265.65 billion by 2035 at a CAGR of...
-
SALT LAKE CITY, April 07, 2026 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a U.S.-based provider of advanced all-domain drone and robotic solutions for...
-
Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "High-Performance Fibers Market - Products and Applications" has been added to ResearchAndMarkets.com's offering. The global high-performance...
-
Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Pigments & Dyes Market - Types, Formulations and Applications" report has been added to ResearchAndMarkets.com's offering. Global market...
-
HMS Networks AB (publ) offentliggör sin rapport för det första kvartalet 2026 torsdagen den 23 april 2026 klockan 07.30. Samma dag klockan 09.00 arrangeras en telefonkonferens för press och...
-
– Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ionizable POZ lipids to replace current ionizable lipids...
-
STAFFORD, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...